Kazuo Nishimura Selected Research

Pain (Aches)

1/2024	Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan.
1/2021	Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study.
8/2013	Weekly low-dose docetaxel combined with estramustine and dexamethasone for Japanese patients with metastatic castration-resistant prostate cancer.
11/2002	[Hormonal chemotherapy for hormone-refractory prostate cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuo Nishimura Research Topics

Disease

58	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 02/2002
39	Neoplasms (Cancer) 01/2024 - 06/2002
29	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 07/2002
20	Neoplasm Metastasis (Metastasis) 05/2023 - 11/2002
10	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 07/2005
7	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2023 - 10/2002
7	Lymphatic Metastasis 09/2021 - 10/2006
6	Disease Progression 01/2022 - 10/2006
5	Testicular Neoplasms (Testicular Cancer) 11/2023 - 10/2002
5	Carcinoma (Carcinomatosis) 09/2017 - 03/2002
4	Pain (Aches) 01/2024 - 11/2002
4	Anemia 01/2023 - 01/2008
4	Infections 04/2021 - 10/2004
4	Kidney Neoplasms (Kidney Cancer) 04/2021 - 06/2007
4	Hemorrhage 08/2018 - 04/2006
3	Hepatitis 01/2024 - 09/2021
3	Thrombocytopenia (Thrombopenia) 07/2016 - 11/2013
3	Carcinoma in Situ 03/2010 - 06/2002
2	Abdominal Pain (Pain, Abdominal) 01/2024 - 03/2002
2	Renal Insufficiency (Renal Failure) 04/2023 - 06/2003
2	Lung Abscess 04/2022 - 05/2014
2	Pneumonia (Pneumonitis) 01/2022 - 09/2021
2	Melanoma (Melanoma, Malignant) 05/2021 - 04/2021
2	Exanthema (Rash) 01/2021 - 11/2011
2	Communicable Diseases (Infectious Diseases) 05/2020 - 09/2015
2	Lymphoma (Lymphomas) 02/2020 - 06/2007
2	Margins of Excision 01/2017 - 04/2012
2	Pleural Effusion (Pleural Effusions) 10/2016 - 07/2002
2	Urinary Tract Infections (Urinary Tract Infection) 09/2015 - 03/2002
2	Insulin Resistance 06/2015 - 01/2005
2	Brain Neoplasms (Brain Tumor) 01/2014 - 11/2009
2	Seminoma 01/2010 - 09/2009

Drug/Important Bio-Agent (IBA)

19	AndrogensIBA 12/2023 - 03/2002
10	Docetaxel (Taxotere)FDA Link 05/2023 - 01/2008
9	Hormones (Hormone)IBA 12/2023 - 11/2002
8	NivolumabIBA 01/2023 - 07/2020
7	Cisplatin (Platino)FDA LinkGeneric 04/2023 - 10/2006
7	enzalutamideIBA 05/2022 - 01/2016
7	Prostate-Specific Antigen (Semenogelase)IBA 02/2020 - 11/2002
7	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 01/2008
6	Axitinib (AG 013736)IBA 01/2024 - 10/2016
6	Immune Checkpoint InhibitorsIBA 02/2023 - 01/2021
6	Sorafenib (BAY 43-9006)FDA Link 09/2018 - 07/2011
5	Androgen Receptors (Androgen Receptor)IBA 05/2023 - 02/2002
5	Sunitinib (Sutent)FDA Link 07/2020 - 12/2012
5	Proteins (Proteins, Gene)FDA Link 07/2015 - 03/2002
4	Tyrosine Kinase InhibitorsIBA 03/2023 - 01/2016
4	Everolimus FDA Link 07/2020 - 11/2013
3	Radium-223IBA 01/2024 - 01/2021
3	pembrolizumabIBA 01/2024 - 01/2020
3	Therapeutic UsesIBA 12/2023 - 03/2022
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2023 - 01/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2018 - 11/2002
3	InterferonsIBA 10/2016 - 04/2013
3	C-Reactive ProteinIBA 07/2016 - 10/2004
3	NF-kappa B (NF-kB)IBA 01/2008 - 06/2006
3	Messenger RNA (mRNA)IBA 06/2005 - 03/2002
2	Prednisolone (Predate)FDA LinkGeneric 01/2024 - 04/2013
2	Gemcitabine FDA Link 04/2023 - 11/2020
2	nedaplatinIBA 04/2023 - 06/2007
2	cabozantinibIBA 03/2023 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 03/2023 - 01/2022
2	cabazitaxel FDA Link 01/2023 - 02/2020
2	taxaneIBA 01/2023 - 01/2022
2	IpilimumabIBA 10/2022 - 04/2022
2	abirateroneIBA 05/2022 - 01/2022
2	olaparibIBA 05/2022 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2021 - 05/2014
2	SteroidsIBA 04/2021 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 10/2006
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 06/2007
2	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 03/2002
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 06/2015 - 01/2005
2	Insulin (Novolin)FDA Link 06/2015 - 01/2005
2	Dihydrotachysterol (AT 10)IBA 07/2014 - 06/2013
2	Estramustine FDA Link 02/2014 - 08/2013
2	Interferon-alpha (Interferon Alfa)IBA 09/2012 - 04/2009
2	Scavenger Receptors (Scavenger Receptor)IBA 06/2010 - 02/2009
2	Conditioned Culture MediaIBA 01/2010 - 06/2005

Therapy/Procedure

60	Therapeutics 01/2024 - 03/2002
26	Drug Therapy (Chemotherapy) 04/2023 - 03/2002
24	Castration 01/2024 - 08/2010
14	Nephrectomy 01/2024 - 03/2002
13	Radiotherapy 12/2023 - 10/2006
11	Prostatectomy (Retropubic Prostatectomy) 01/2017 - 01/2004
4	Aftercare (After-Treatment) 01/2024 - 01/2005
4	Molecular Targeted Therapy 07/2016 - 06/2006
3	Drug Tapering 01/2024 - 11/2011
3	Immunotherapy 04/2022 - 12/2012
3	Adrenalectomy 04/2020 - 04/2006
3	Oral Administration 01/2019 - 06/2007
3	Nephroureterectomy 09/2017 - 06/2002
3	Metastasectomy 12/2011 - 07/2010
3	Orchiectomy (Orchidectomy) 09/2009 - 07/2006
2	Operative Surgical Procedures 01/2021 - 09/2016
2	Lymph Node Excision (Lymph Node Dissection) 03/2020 - 10/2002
2	Cystectomy 09/2017 - 07/2012
2	Brachytherapy 01/2017 - 07/2006
2	Operative Time 12/2013 - 01/2008
2	Adjuvant Chemotherapy 07/2013 - 10/2012